Friday, April 6, 2007

8th Annual Spring Research Briefing Podcast

The New England Chapter's 8th Annual Spring Research Briefing was held on Tuesday, March 27, 2007 at the Westin Waltham-Boston Hotel in Waltham, MA.

The information we shared that night was an inspiration and surely proof that our quest for a cure is closer to reality than ever. We are happy to share with you a Podcast of the evening's program.

A special thank you to Paul Kekejian and Brandon Smith of Bentley College, and to their professor, Mark Frydenberg, for helping to make this Podcast possible!

Welcome Address from David Bennett, JDRF Bay State Branch Board President

Subscribe with iTunes:
itpc://feeds.feedburner.com/jdrfne.

With something else (copy this address):
http://feeds.feedburner.com/JdrfNe.

Dr. William Tamborlane's Presentation

Presentation from Dr. William Tamborlane, Yale University School of Medicine

View Dr. Tamborlane's PowerPoint Presentation.


Subscribe with iTunes:
itpc://feeds.feedburner.com/jdrfne.

With something else (copy this address):
http://feeds.feedburner.com/JdrfNe.


Dr. William Tamborlane is Professor and Chief of Pediatric Endocrinology and Diabetes at Yale University School of Medicine in New Haven, CT, as well as Deputy Program Director of the Yale General Clinical Research Center. The focus of Dr. Tamborlane’s research has been to advance the treatment of diabetes through patient-oriented research. His current research effort is directed at applying recent advance in insulin pump and glucose sensor technology towards the development of an artificial pancreas and he serves as the Steering Committee Chair of the Diabetes Research in Children’s Network (DirectNet), a NIH multicenter group that is testing glucose sensing systems in children.

Dr. Kevan Herold's Presentation

Presentation from Dr. Kevan Herold, Yale University School of Medicine

View Dr. Herold's PowerPoint Presentation.

Subscribe with iTunes:
itpc://feeds.feedburner.com/jdrfne.

With something else (copy this address):
http://feeds.feedburner.com/JdrfNe.


Dr. Kevan Herold is Professor of Immunobiology and Medicine at Yale University. He is the Director of the TrialNet Center at Yale and was the Medical Director of the Columbia University Islet Transplant center. The focus of his investigative work is on developing new ways to prevent and treat type 1 diabetes. He has studied and is developing novel immunologic and metabolic approaches that have been able to prevent the progression of type 1 diabetes and is involved in a number of national and international clinical studies of new treatments. He initially reported on the use of anti-CD3 monoclonal antibody to treat patients with new onset type 1 diabetes that is now in development for treatment. His clinical interests are in management of diabetes, complications of diabetes, and complications as well as other endocrine diseases.